FAQ
Most frequent questions and answers
Appetite changes often show up within the first few weeks, while meaningful weight change builds gradually as your dose is titrated. In STEP 1, weight loss in the semaglutide group was observed from the first post-randomization assessment at week 4 onward, reaching a nadir at week 60. Your timeline is your own.
The most common are gastrointestinal. In STEP 1, nausea and diarrhea were the most common adverse events with semaglutide; they were typically transient, mild to moderate in severity, and subsided with time. Our check-in schedule exists to catch and manage them early.
Tell us everything you take at your consultation, including supplements. Some combinations need caution: low blood sugar can occur when semaglutide is used with other medicines that lower blood sugar, including insulin or sulfonylureas. This page is for education, not individualized medical advice.
Semaglutide and tirzepatide are two commonly discussed options: tirzepatide acts on GLP-1 and GIP receptors. Read how semaglutide compares to tirzepatide, or see our pages on tirzepatide injections in Reno and Zepbound weight loss injections.
Monthly cost varies with your dose, program length, and included services. We review exact pricing at your consultation instead of publishing a figure that might not apply to you.